• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2017-2020 年 NHANES 中成年人身体活动与 MAFLD/MASLD 和 LF 的关系。

Association of physical activity with MAFLD/MASLD and LF among adults in NHANES, 2017-2020.

机构信息

Zhujiang Hospital of Southern Medical University, 510150, Guangzhou, Guangdong, China.

出版信息

Wien Klin Wochenschr. 2024 May;136(9-10):258-266. doi: 10.1007/s00508-023-02314-0. Epub 2024 Jan 3.

DOI:10.1007/s00508-023-02314-0
PMID:38170220
Abstract

OBJECTIVES

To investigate the correlations between physical activity (PA) and metabolic associated fatty liver disease (MAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD) within a substantial population-based survey, and to examine the association between PA and liver fibrosis (LF).

METHODS

Data from the 2017-2020 NHANES cycle were utilized in this study. PA was divided into four types: leisure-time PA (LTPA), transportation-related PA (TPA), occupational PA (OPA) and total time PA (total PA, which is composed of OPA, TPA and LTPA). Weighted logistic regression models were performed to analyze the associations between PA and MAFLD/MASLD and LF. Mediation analysis was used to explore whether LTPA completely mediated the statistically significant relationship between total PA and MAFLD/MASLD or LF.

RESULTS

The study encompassed a sample size of 5897 participants aged 20 years and above, among the total participants, 2568 individuals with MAFLD and 2588 individuals with MASLD. There was no statistically significant correlation observed between OPA/TPA and MAFLD/MASLD and LF; however, active LTPA demonstrated an inverse association with MAFLD/MASLD (OR: 0.548; 95% CI: 0.458, 0.656/OR: 0.543; 95% CI: 0.453, 0.650), as well as a negative correlation with significant/advanced LF (OR: 0.457; 95% CI: 0.334,0.625/OR: 0.427; 95% CI: 0.295,0.619). There was also a significant inverse association between total PA and MAFLD/MASLD or LF, but this association was carried by the difference in LTPA.

CONCLUSION

Participation in active LTPA is associated with a reduced likelihood of MAFLD/MASLD and LF, while neither OPA nor TPA can replace these effects of LTPA.

摘要

目的

在一项大规模基于人群的调查中,研究体力活动(PA)与代谢相关脂肪性肝病(MAFLD)或代谢相关脂肪性肝损伤(MASLD)之间的相关性,并探讨 PA 与肝纤维化(LF)之间的关系。

方法

本研究利用 2017-2020 年 NHANES 周期的数据。将 PA 分为四种类型:休闲时间 PA(LTPA)、交通相关 PA(TPA)、职业 PA(OPA)和总时间 PA(total PA,由 OPA、TPA 和 LTPA 组成)。采用加权 logistic 回归模型分析 PA 与 MAFLD/MASLD 和 LF 之间的关系。采用中介分析探讨 LTPA 是否完全介导了总 PA 与 MAFLD/MASLD 或 LF 之间具有统计学意义的关系。

结果

本研究纳入了 5897 名年龄在 20 岁及以上的参与者,其中 2568 名患有 MAFLD,2588 名患有 MASLD。OPA/TPA 与 MAFLD/MASLD 和 LF 之间没有统计学上的相关性;然而,积极的 LTPA 与 MAFLD/MASLD 呈负相关(OR:0.548;95%CI:0.458,0.656/OR:0.543;95%CI:0.453,0.650),与显著/进展性 LF 也呈负相关(OR:0.457;95%CI:0.334,0.625/OR:0.427;95%CI:0.295,0.619)。总 PA 与 MAFLD/MASLD 或 LF 之间也存在显著的负相关,但这种相关性是由 LTPA 的差异引起的。

结论

积极参与 LTPA 与 MAFLD/MASLD 和 LF 的发生风险降低有关,而 OPA 和 TPA 均不能替代 LTPA 的这些作用。

相似文献

1
Association of physical activity with MAFLD/MASLD and LF among adults in NHANES, 2017-2020.2017-2020 年 NHANES 中成年人身体活动与 MAFLD/MASLD 和 LF 的关系。
Wien Klin Wochenschr. 2024 May;136(9-10):258-266. doi: 10.1007/s00508-023-02314-0. Epub 2024 Jan 3.
2
Independent and joint association of physical activity and adequate weekday sleep duration with metabolic dysfunction-associated steatotic liver disease.独立和联合的身体活动和充足的工作日睡眠时间与代谢功能障碍相关的脂肪性肝病的关系。
Clin Res Hepatol Gastroenterol. 2024 Apr;48(4):102320. doi: 10.1016/j.clinre.2024.102320. Epub 2024 Mar 12.
3
MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease.MAFLD 标准比 MASLD 标准更能预测慢性肾脏病的风险。
Ann Hepatol. 2024 Sep-Oct;29(5):101512. doi: 10.1016/j.aohep.2024.101512. Epub 2024 May 6.
4
MAFLD predicts cardiovascular disease risk better than MASLD.MAFLD 预测心血管疾病风险优于 MASLD。
Liver Int. 2024 Jul;44(7):1567-1574. doi: 10.1111/liv.15931. Epub 2024 Apr 20.
5
MAFLD identifies patients with significant hepatic fibrosis better than MASLD.MAFLD 在识别有显著肝纤维化的患者方面优于 MASLD。
Hepatol Int. 2024 Jun;18(3):964-972. doi: 10.1007/s12072-024-10673-7. Epub 2024 May 8.
6
Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians.代谢相关脂肪性肝病命名对脂肪性肝病患病率和筛查的影响:亚洲前瞻性人群调查。
J Gastroenterol Hepatol. 2024 Aug;39(8):1636-1647. doi: 10.1111/jgh.16554. Epub 2024 May 2.
7
Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults.美国成年人中NAFLD、MAFLD和MASLD的特征及死亡率结果比较。
Liver Int. 2024 Apr;44(4):1051-1060. doi: 10.1111/liv.15856. Epub 2024 Jan 31.
8
The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults.青少年/年轻成年人代谢功能相关脂肪性肝病和纤维化/肝硬化的流行情况及其预测因素。
J Pediatr Gastroenterol Nutr. 2024 Jul;79(1):110-118. doi: 10.1002/jpn3.12219. Epub 2024 Apr 16.
9
Severity and Remission of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence.慢性肾脏病发生时代谢功能障碍相关脂肪/脂肪变性肝病的严重程度和缓解情况。
J Am Heart Assoc. 2024 Mar 5;13(5):e032604. doi: 10.1161/JAHA.123.032604. Epub 2024 Feb 23.
10
Association between neutrophil-to-high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease and liver fibrosis in the US population: a nationally representative cross-sectional study using NHANES data from 2017 to 2020.中性粒细胞与高密度脂蛋白胆固醇比值与美国人群代谢功能障碍相关脂肪性肝病和肝纤维化的关系:基于 2017 年至 2020 年 NHANES 数据的全国代表性横断面研究
BMC Gastroenterol. 2024 Sep 5;24(1):300. doi: 10.1186/s12876-024-03394-6.

引用本文的文献

1
The Impact of Social Determinants of Health on Metabolic Dysfunction-Associated Steatotic Liver Disease Among Adults in the United States.社会健康决定因素对美国成年人代谢功能障碍相关脂肪性肝病的影响
J Clin Med. 2025 Aug 4;14(15):5484. doi: 10.3390/jcm14155484.
2
The Role of Global Physical Capacity Score in Key Parameters of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).全球身体能力评分在代谢功能障碍相关脂肪性肝病(MASLD)关键参数中的作用
J Clin Med. 2025 May 29;14(11):3821. doi: 10.3390/jcm14113821.
3
[Different Types of Obesity Play a Modifying Role in the Association Between Physical Activity and Metabolic Dysfunction-Associated Fatty Liver Disease].

本文引用的文献

1
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.全球非酒精性脂肪性肝病的患病率和发病率:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861. doi: 10.1016/S2468-1253(22)00165-0. Epub 2022 Jul 5.
2
Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease.体力活动与非酒精性脂肪性肝病患者肝纤维化、肌肉减少症和心血管疾病风险的相关性。
Clin Gastroenterol Hepatol. 2023 Feb;21(2):358-369.e12. doi: 10.1016/j.cgh.2021.12.043. Epub 2022 Jan 6.
3
The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease.
[不同类型的肥胖在体力活动与代谢功能障碍相关脂肪性肝病的关联中起调节作用]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Jan 20;56(1):149-155. doi: 10.12182/20250160108.
4
Association of occupational physical activity and sedentary behaviour with the risk of hepatocellular carcinoma: a case-control study based on the Inpatient Clinico-Occupational Database of Rosai Hospital Group.职业体力活动和久坐行为与肝细胞癌风险的关联:一项基于罗萨伊医院集团住院临床职业数据库的病例对照研究
BMJ Open. 2025 Mar 12;15(3):e092020. doi: 10.1136/bmjopen-2024-092020.
5
Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases.慢性肝胆疾病的当前治疗方案及有前景的分子疗法
Biomolecules. 2025 Jan 14;15(1):121. doi: 10.3390/biom15010121.
6
Sonographic Features of Rectus Femoris Muscle in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease and Their Correlation with Body Composition Parameters and Muscle Strength: Results of a Single-Center Cross-Sectional Study.代谢功能障碍相关脂肪性肝病患者股直肌的超声特征及其与身体成分参数和肌肉力量的相关性:一项单中心横断面研究的结果
Biomedicines. 2024 Jul 28;12(8):1684. doi: 10.3390/biomedicines12081684.
7
Leisure-Time Physical Activity in Subjects with Metabolic-Dysfunction-Associated Steatotic Liver Disease: An All-Cause Mortality Study.代谢功能障碍相关脂肪性肝病患者的休闲体力活动:一项全因死亡率研究。
J Clin Med. 2024 Jun 27;13(13):3772. doi: 10.3390/jcm13133772.
中华医学会肝病学分会关于脂肪肝疾病重新定义的立场声明。
J Hepatol. 2021 Aug;75(2):454-461. doi: 10.1016/j.jhep.2021.05.003. Epub 2021 May 19.
4
Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending?线粒体动力学与非酒精性脂肪性肝病(NAFLD):童话般结局的新视角?
Metabolism. 2021 Apr;117:154708. doi: 10.1016/j.metabol.2021.154708. Epub 2021 Jan 11.
5
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.亚太肝病学会代谢相关性脂肪性肝病临床诊疗指南。
Hepatol Int. 2020 Dec;14(6):889-919. doi: 10.1007/s12072-020-10094-2. Epub 2020 Oct 1.
6
The times they are a-changin' (for NAFLD as well).时代在变(非酒精性脂肪性肝病亦是如此)。
J Hepatol. 2020 Dec;73(6):1307-1309. doi: 10.1016/j.jhep.2020.08.028. Epub 2020 Sep 2.
7
From NAFLD to MAFLD: Implications of a Premature Change in Terminology.从非酒精性脂肪性肝病到代谢相关脂肪性肝病:术语过早改变的影响。
Hepatology. 2021 Mar;73(3):1194-1198. doi: 10.1002/hep.31420. Epub 2021 Feb 6.
8
Are Lifestyle Therapies Effective for NAFLD Treatment?生活方式疗法对非酒精性脂肪性肝病治疗有效吗?
Trends Endocrinol Metab. 2019 Oct;30(10):701-709. doi: 10.1016/j.tem.2019.07.013. Epub 2019 Aug 15.
9
Diabetes Prevalence by Leisure-, Transportation-, and Occupation-Based Physical Activity Among Racially/Ethnically Diverse U.S. Adults.美国不同种族/族裔成年人基于休闲、交通和职业的体力活动的糖尿病患病率。
Diabetes Care. 2019 Jul;42(7):1241-1247. doi: 10.2337/dc18-2432. Epub 2019 May 21.
10
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.亚洲地区非酒精性脂肪性肝病的流行率、发病率和结局:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2019 May;4(5):389-398. doi: 10.1016/S2468-1253(19)30039-1. Epub 2019 Mar 20.